Constructing a Synthetic Metabolic Pathway in Escherichia Coli to Produce the Enantiomerically Pure (R, R)-2,3-Butanediol
Constructing a Synthetic Metabolic Pathway in Escherichia Coli to Produce the Enantiomerically Pure (R, R)-2,3-Butanediol
复制标题
在大肠杆菌中构建合成代谢途径以生产对映体纯的 (R, R)-2,3-丁二醇。
DOI:
10.1002/bit.25512
复制
发表时间:
2015-05-01
影响因子:
3.8
通讯作者:
Huang, He
中科院分区:
文献类型:
--
作者:
Ji, Xiao-Jun;Liu, Lu-Gang;Huang, He
Enantiomerically pure (R, R)-2,3-butanediol has unique applications due to its special chiral group and spatial configuration. Currently, its chemical production route has many limitations. In addition, no native microorganisms can accumulate (R, R)-2,3-butanediol with an enantio-purity over 99%. Herein, we constructed a synthetic metabolic pathway for enantiomerically pure (R, R)-2,3-butanediol biosynthesis in Escherichia coli. The fermentation results suggested that introduction of the synthetic metabolic pathway redistributed the carbon fluxes to the neutral (R, R)-2,3-butanediol, and thus protected the strain against the acetic acid inhibition. Additionally, it showed that the traditionally used isopropyl beta-D-thiogalactoside (IPTG) induction displayed negative effect on (R, R)-2,3-butanediol biosynthesis in the recombinant E. coli, which was probably due to the protein burden. With no IPTG addition, the (R, R)-2,3-butanediol concentration reached 115g/L by fed-batch culturing of the recombinant E. coli, with an enantio-purity over 99%, which is suitable for the pilot-scale production. Biotechnol. Bioeng. 2015;112: 1056-1059. (c) 2014 Wiley Periodicals, Inc.